PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-07

Date Title Company
07-Nov-2024 Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit AccessWire
07-Nov-2024 Global High Content Screening Market Poised for Significant Growth, Projected to Surpass USD 3 Billion by 2033 at a 5.8% of CAGR MARKITWIRED
07-Nov-2024 CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024 CureVac
07-Nov-2024 TRNR Announces 1-for-100 Reverse Split AccessWire
07-Nov-2024 Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update Immunic AG
07-Nov-2024 Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates AccessWire
07-Nov-2024 Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement Hanson Wade
07-Nov-2024 NHSBSA publishes latest prescribing costs report NHSBSA
07-Nov-2024 Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration Lisata Therapeutics
07-Nov-2024 Research shows caterpillar fungus can slow down growth of cancer cells University of Nottingham
07-Nov-2024 PulseSight Therapeutics Presents New Data on PST-611 Transferrin Vectorized Therapy for Geographic Atrophy at EVER Congress 2024 PulseSight Therapeutics
07-Nov-2024 New flexible sensor can improve compression therapy Edinburgh Innovations
07-Nov-2024 New ultrasonic air bubble de-tector 300 µm AD-102 AMSYS
07-Nov-2024 Multimillion major new funding for developing and delivering solutions for people with dementia The UK Dementia Research Institute
07-Nov-2024 Bristol Myers Squibb Creates New Leadership Role, Appointing Karen Costello as General Manager for Ireland Bristol Myers Squibb
07-Nov-2024 Genmab Announces Financial Results for the First Nine Months of 2024 Genmab
07-Nov-2024 Enteralia Bioscience SRL Acquires TFarma SRL AccessWire
07-Nov-2024 RHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed   RHÖN-KLINIKUM Aktiengesellschaft
07-Nov-2024 Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth Cantourage Group SE
07-Nov-2024 APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted APONTIS PHARMA AG